Mpox, previously known as monkeypox, is once again a global health concern with a new outbreak in Guinea Bissau marking the country's first encounter with the virus. This resurgence brings the total number of lab-confirmed mpox cases worldwide since 2022 to nearly 190,000 across 145 nations. Historically, mpox outbreaks were confined to a few African countries where the virus is endemic, often originating from contact with infected wild animals.

The disease typically begins with flu-like symptoms such as fever, chills, and muscle aches, progressing to a characteristic rash that evolves from raised spots to fluid-filled blisters and eventually scabs. The virus was first identified in monkeys in 1958, leading to its original name. However, the World Health Organization (WHO) recommended the change to mpox during the 2022 international outbreak to mitigate racist and stigmatizing language.

While mpox has long been endemic in parts of Africa, with outbreaks historically linked to the consumption of meat from infected wild animals, recent years have seen a significant shift. Sustained human-to-human transmission has facilitated its spread beyond traditional endemic regions. The Centers for Disease Control and Prevention (CDC) in the United States has indicated that mpox is on track to become endemic in the U.S.

The current spread to new countries raises questions about containment strategies and the evolving nature of the virus. The two main types, clade I and clade II, historically known as the Congo Basin and West African clades respectively, are key to understanding transmission patterns. The 2022 global outbreak was primarily driven by clade II.

Experts are closely monitoring the current situation, particularly the apparent increased impact on children in recent outbreaks. This observation, alongside the virus's expansion into previously unaffected territories, underscores the need for updated public health responses and continued surveillance. The implications for global health security are significant, requiring coordinated international efforts to prevent further spread and manage existing cases.

Public health agencies are working to understand the factors contributing to this wider geographical distribution and the specific vulnerabilities that may be leading to more severe outcomes in certain populations. The history of mpox shows a pattern of emergence and re-emergence, often linked to environmental changes and human behavior.

Further research is crucial to identify the precise mechanisms driving the current outbreak dynamics. This includes understanding the role of different clades, potential mutations, and the effectiveness of existing preventative measures and treatments. The global health community faces the challenge of adapting its strategies to this persistent and evolving threat.

Questions remain regarding the long-term trajectory of mpox and its potential to become permanently established in new regions. Continued vigilance, robust public health infrastructure, and international cooperation will be essential in navigating this ongoing health challenge.